Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lopez, Michael L
NCT03992430 / 2018-001762-42: A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)	Active, not recruiting	3	160	Europe, US, RoW	Eteplirsen, AVI-4658, EXONDYS 51, EXONDYS	Sarepta Therapeutics, Inc., Sarepta Therapeutics, Inc.	Muscular Dystrophy, Duchenne	11/24	11/24
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Recruiting	3	436	US, RoW	Udenafil, Placebo	Mezzion Pharma Co. Ltd	Single Ventricle Heart Disease	10/25	10/25
Caswell, Linda
No trials found